ASCO Connection

July 2017

Issue link: http://read.uberflip.com/i/845028

Contents of this Issue

Navigation

Page 35 of 67

FEATURES ASCO Welcomes 2017-2018 Board of Directors TREASURER Craig R. Nichols, MD, FASCO, is the co-director of the Testicular Cancer Multidisciplinary Clinic at Virginia Mason Medical Center in Seat- tle. He serves as co-primary investiga- tor on the recently funded Northwest National Cancer Institute Community Oncology Research Program. Dr. Nich- ols is the executive officer of Cancer Control and Prevention Research for the Southwest Oncology Group. Board Members PEDIATRIC ONCOLOGIST Peter C. Adamson, MD, is chair of the Chil- dren's Oncology Group, president of the Children's Oncology Group Foundation, and a professor of pediatrics and pharmacology at The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania. UNDESIGNATED SPECIALIST Charles D. Blanke, MD, FACP, FASCO, is a pro- fessor of medicine in the Division of Hematology and Medical Oncology at Oregon Health & Science University's Knight Cancer Institute. COMMUNITY ONCOLOGIST Linda Bosserman, MD, FACP, FASCO, is an assistant clinical profes- sor and staff physician at City of Hope. RADIATION ONCOLOGIST Walter J. Curran Jr., MD, FACR, is the execu- tive director of the Win- ship Cancer Institute of Emory Univer- sity, the Lawrence W. Davis Professor and Chair of Emory's Department of Radiation Oncology, and the associate vice president for cancer at the Wood- ruff Health Sciences Center. SURGICAL ONCOLOGIST Stephen B. Edge, MD, FACS, FASCO, is the director of the Baptist Cancer Center and an adjunct profes- sor of surgery at the Vanderbilt Univer- sity School of Medicine. UNDESIGNATED SPECIALIST Arti Hurria, MD, FASCO, is director of the Cancer and Aging Research Pro- gram, co-leader of the Cancer Control and Population Sciences Program, and associate professor of medical oncol- ogy and therapeutics research at City of Hope. UNDESIGNATED SPECIALIST Maha Hussain, MD, FACP, FASCO, is the Cis-Maisel Professor of Oncology, and professor of medicine and urology at the University of Michi- gan Comprehensive Cancer Center (UMCCC). Dr. Hussain has also served as the associate director for clinical Board Officers 2017-2018 PRESIDENT Bruce E. Johnson, MD, FASCO, is chief clinical research officer and institute physician at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He is the director of the Dana-Farber/ Harvard Cancer Center (DF/HCC) Lung Cancer Program. 2017-2018 PRESIDENT-ELECT Monica M. Bertagnolli, MD, FASCO, is chief of the Division of Surgical Oncology at Dana-Farber/Brigham and Women's Cancer Center, a professor of surgery at Harvard Medical School, and an associate surgeon at Brigham and Women's Hospital and Dana-Farber Cancer Institute. IMMEDIATE PAST PRESIDENT Daniel F. Hayes, MD, FACP, FASCO, is a pro- fessor of internal medi- cine, the Stuart B. Padnos Professor in Breast Cancer, and the clinical director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. ASCO is pleased to welcome the 2017-2018 ASCO Board of Directors and intro- duce four newly instated leaders, who began their terms at the conclusion of the Annual Business Meeting during the 2017 ASCO Annual Meeting in Chicago. 34ā€‚Iā€‚07.2017

Articles in this issue

Archives of this issue

view archives of ASCO Connection - July 2017